SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

Cue Health developed a rapid COVID-19 test that's become the new gold standard: fast, reliable, and easy to use. The company is now getting ready to IPO.

Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...

Cue Health (HLTH) made a name for itself with a rapid at-home COVID-19 test, a machine with a $200 price tag, and is out with 13 new tests this week, though none is compatible with the new machine.

The Cue Health Monitoring System has many new tests on the way, and we’re very excited about the progress and our key priority of menu expansion. We’re also happy to see the peer-review publication of ...

Cue Health, a San Diego biotechnology company that grew rapidly from producing COVID-19 tests, is laying off roughly one-third of its global workforce. Early in the coronavirus pandemic, Cue Health ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights “We reached several ...

SAN DIEGO, July 10, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company developing a range of diagnostic products for professionals and consumers, announced today it has ...

Good day, and thank you for standing by. Welcome to the Cue Health Fourth Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions].